Actinobacillus actinomycetemcomitans, the etiologic agent of localized juvenile periodontitis, produces a potent leukotoxin that kills human neutrophils. The production of leukotoxin RNA can vary more than 50-fold among isolates of A. actinomycetemcomitans, and strains expressing high levels of leukotoxin RNA are most often found at sites of periodontal disease. To assess the relative contributions of transcription factors and promoter sequences in setting the disparate levels of leukotoxin RNA found, we have undertaken classical cis/trans analyses. First, the leukotoxin promoter regions from moderately leukotoxic (Y4) and minimally leukotoxic (ATCC 33384) strains of A. actinomycetemcomitans were cloned, sequenced, and compared with the previously sequenced leukotoxin promoter region of the high-producer strain JP2. The Y4 and ATCC 33384 promoter regions each contain a 528-bp segment that is absent from JP2. Interestingly, the analysis of various deletion constructs in A. actinomycetemcomitans indicated that Y4, despite the large insertion, initiates leukotoxin RNA synthesis at the same promoter as JP2 does. To perform cis/trans analyses, these three leukotoxin promoter regions were cloned into a plasmid upstream of the reporter gene ␤-galactosidase. Each plasmid was transformed into JP2, Y4, and ATCC 33384, and the ␤-galactosidase levels were determined. The results indicated that the sequences responsible for down-regulating leukotoxin RNA levels in Y4 relative to JP2 are found within the transcribed region of the Y4 leukotoxin operon. Importantly, in ATCC 33384, strain-specific trans factors and promoter sequence differences are equally significant in determining the lower levels of leukotoxin RNA. We hypothesize that either strain ATCC 33384 has a negative regulatory protein (which is missing or mutated in JP2/Y4) or that JP2 and Y4 carry an activator that is missing or mutated in ATCC 33384.
The gram-negative bacterium Actinobacillus actinomycetemcomitans is considered to be a primary pathogenic agent in various periodontal diseases, especially localized juvenile periodontitis (24, 32) . Although A. actinomycetemcomitans has been purported to have numerous virulence factors, the one that has garnered the most attention is a 116-kDa protein called leukotoxin (28) . This toxin specifically lyses human and primate polymorphonuclear leukocytes (29, 34) and thus is assumed to help the bacterium evade the innate host immune defense system. The contention that leukotoxin is a virulence factor is supported by the finding that it is produced in most strains of A. actinomycetemcomitans isolated from patients with periodontitis but is not usually produced in the few isolates that can be cultured from healthy individuals (33) . The lack of leukotoxin production in some strains of A. actinomycetemcomitans is not due to a deletion of the leukotoxin structural gene, since the operon is present in all strains examined to date (7, 11, 25) . Instead, the strain-specific differences in leukotoxin levels correlate with the amount of leukotoxin RNA produced (25) . The mechanisms responsible for the interstrain regulation of leukotoxin RNA are unknown.
To allow a molecular analysis of leukotoxin function and regulation, the gene for this toxin has been cloned and sequenced (16) (17) (18) . The protein encoded by the leukotoxin structural gene (lktA) is a member of the RTX family of toxins, whose prototypical member is the ␣-hemolysin from Escherichia coli. Like many of the genes encoding RTX proteins, the lktA gene is found within an operon that contains four genes (3, 30) . The other three genes, lktC, lktB, and lktD, encode proteins that are presumably involved in the activation and localization of the leukotoxin; this has been shown for their homologs in the ␣-hemolysin operon of E. coli (4, 10, 12, 13, 30) . Two transcripts derive from the leukotoxin operon: a minor ϳ9.5-kb species, which contains the sequences of all four genes, and a predominant ϳ4.3-kb RNA, which contains only the lktC and lktA sequences (25) . Brogan et al. (5) recently presented an analysis of the leukotoxin promoter regions from A. actinomycetemcomitans JP2, a high-level leukotoxin expresser, and from strain 652, which produces about 5% of the JP2 levels of LktA. They identified two leukotoxin RNA start sites in JP2 by primer extension; both of these have potential Ϫ10 and Ϫ35 promoter sequences associated with them. One promoter, called P 1 , is 350 bp upstream of lktC, and the second, called P 2 , is only 50 bp in front of lktC. Interestingly, the sequence of the region upstream of lktC from strain 652 revealed an insertion of 528 bp between the P 1 and P 2 promoters. This additional sequence has an open reading frame (which we will refer to as orfX) that has the potential to encode a 150-amino-acid protein in strain 652, whereas JP2 could produce only a truncated version of this protein. The position of the leukotoxin promoter in strain 652 was not determined experimentally, nor did the sequence comparison of Brogan et al. (5) provide any strong clues to the mechanism by which these two operons express different levels of leukotoxin RNA.
None of the previous studies investigating the mechanisms of interstrain differences in leukotoxin levels have examined the possibility that strain-specific transcription factors play a role. To assess the relative contributions of transcription factors and leukotoxin promoter sequences (cis elements) in setting the disparate levels of leukotoxin RNA in different strains of A. actinomycetemcomitans, we have undertaken classical cis/trans analyses. As a first step, we cloned and sequenced the leukotoxin promoter regions from three strains of A. actinomycetemcomitans: JP2, a high-level leukotoxin producer; Y4, a moderate-level producer of LktA (10% of the level produced by JP2); and ATCC 33384, which produces only 2% as much leukotoxin as JP2 (25) . RNA end mapping and other strategies have been used with JP2 and Y4 to show that, unlike the results reported by Brogan et al. (5) , leukotoxin RNA is transcribed only from the P 1 promoter. Sequence comparisons and classic cis/trans tests with leukotoxin promoter reporter gene plasmids in A. actinomycetemcomitans were used to demonstrate that the extra 528 bp in Y4 relative to JP2 contain the sequences responsible for determining the lower level of lkt RNA in Y4. Interestingly, similar analyses with the ATCC 33384 promoter region indicated that DNA element and transcription factor differences are equally important in determining the lower levels of lkt RNA found in strain ATCC 33384.
MATERIALS AND METHODS
Bacterial strains and culture conditions. Three strains of A. actinomycetemcomitans were used: JP2 (29), Y4 (28) , and ATCC 33384 (NCTC 9710) (35) . A. actinomycetemcomitans cells were grown in an anaerobic chamber (Coy Laboratory Products, Ann Arbor, Mich.) (5% CO 2 , 10% H 2 , 85% N 2 ) at 37ЊC in TSBYE (3% tryptic soy broth plus 0.6% yeast extract). The recombinant constructs were propagated in E. coli TB-1 at 37ЊC in Luria broth (1) . Where indicated, spectinomycin was added to a final concentration of 50 g/ml. Ampicillin was used at final concentrations of 50 g/ml for E. coli and 10 g/ml for A. actinomycetemcomitans.
Cloning and sequencing leukotoxin promoter regions from strains Y4 and ATCC 33384. A 7-kb PstI DNA fragment containing the leukotoxin promoter region from A. actinomycetemcomitans ATCC 33384 was cloned from a limited genomic DNA library (16) with an EcoRI fragment internal to the JP2 lktC gene (17) as a hybridization probe; the resulting clone was called pEK30. The same hybridization probe was used to clone a 3-kb PstI DNA fragment containing the leukotoxin promoter region from a limited genomic library (16) of strain Y4 DNA; the resulting clones are called pCJ2 and pCJ6. The DNA sequence of part of each clone was determined by the dideoxy-chain termination method with a Sequenase version 2.0 sequencing kit (U.S. Biochemicals, Cleveland, Ohio). All reported sequences were determined from both strands and were analyzed with the Pustell DNA/protein sequence analysis system (International Biotechnologies, Inc.).
RNA isolation and analysis. A. actinomycetemcomitans RNA was prepared by a sodium dodecyl sulfate (SDS) lysis/CsCl cushion procedure modified from that of Deretic and Konyecsni (6) . A 30-to 50-ml sample of JP2 cells was harvested in the mid-logarithmic phase of growth by centrifugation, washed with cold lysis buffer (50 mM Tris-HCl [pH 7.5], and brought up in 5 ml of lysis buffer to which 1 ml of 20% SDS had been added. After incubation at 37ЊC for 1 to 2 min, 4 g of CsCl was added and mixed in by gentle rocking. An additional 5 ml of lysis buffer was mixed in by gentle inversion, and the precipitate that formed was removed by centrifugation at 11,000 ϫ g for 10 min. The resulting supernatant was removed, and aliquots were layered onto 5.7 M CsCl cushions of equal volume. The RNA was pelleted overnight in an SW50.1 rotor at 150,000 ϫ g for 15ЊC. The tubes were emptied by inversion, and each clear RNA pellet was dissolved in 200 l of water and stored as a precipitate in 67% ethanol in a microcentrifuge tube. All solutions were prepared with diethylpyrocarbonatetreated water, and diethylpyrocarbonate-treated plasticware and baked glassware were used.
Primer extension assays followed the protocol of Welch and Pellet (31) with some minor modifications. Synthetic oligonucleotide primers were radiolabelled with T4 polynucleotide kinase and [␥-
32 P]ATP (1). Between 0.01 and 0.03 pmol of labeled probe was combined with 30 g of A. actinomycetemcomitans RNA in 10 l of reverse transcriptase buffer, and the mixture was heated to 80ЊC for 3 min and then allowed to anneal at 37ЊC for 90 min. Moloney murine leukemia virus (MMLV) reverse transcriptase (200 U; Life Technologies) was added to the reaction mixture along with each deoxynucleoside triphosphate to 0.63 mM, and the mixture incubated for 60 min at 37ЊC. Each sample was then precipitated with ethanol, dried, and dissolved in sequencing sample buffer (1) for electrophoresis on 6% polyacrylamide-urea gels. S1 nuclease analyses were adapted from the protocol of Deretic and Konyecsni (6) . The DNA probes were end labeled with T4 polynucleotide kinase, and 25,000 to 75,000 cpm of each probe was mixed with 20 to 25 g of RNA in 15 l of hybridization buffer [0.83 M NaCl, 1.7 mM piperazine-N,NЈ-bis(2-ethanesulfonic acid) (PIPES; pH 6.5)]. After being boiled for 3 min, the samples were incubated at 67ЊC for 60 min, and then 300 l of iced S1 nuclease buffer and 880 to 1,200 units of S1 nuclease were added. The samples were incubated for 30 min at 37ЊC and then extracted with phenol, precipitated with ethanol, and electrophoresed as described above.
Reverse transcriptase-coupled PCR. The procedure for reverse transcriptasecoupled PCR was modified from that of Pierce et al. (22) . RNA from A. actinomycetemcomitans Y4 was first treated with RNase-free RQ1 DNase (Promega Corp., Madison, Wis.) at 0.25 U/g for 15 min at 37ЊC. After extraction with phenol and chloroform-isoamyl alcohol, the RNA sample was ethanol precipitated and suspended in water to 1 mg/ml. RNA (10 g) was incubated in Moloney murine leukemia virus reverse transcriptase buffer (50 mM Tris-HCl [pH 8.3] , 75 mM KCl, 10 mM dithiothreitol, 3 mM MgCl 2 ) containing 0.12 U of human placental RNase inhibitor (Life Technologies, Gaithersburg, Md.) per l, 0.5 mM each deoxynucleoside triphosphate, 20 ng of primer LKT57 per l and 2 U of MMLV reverse transcriptase (Life Technologies) per l. cDNA synthesis was allowed to proceed for 2 h at 37ЊC, at which point the reaction was stopped by placing the reaction mixture at Ϫ20ЊC. The sample was extracted with phenol and chloroform, ethanol precipitated, and suspended in Tris-EDTA to 0.2 g/l. For PCR amplification, 0.8 g of the cDNA sample was used as a template with 0.5 g of each primer and amplified for 30 cycles (1). The resulting PCR products were electrophoresed on a 1% agarose gel and visualized by staining with ethidium bromide.
Construction of a strain deleted of the chromosomal copy of orfX. Standard recombinant DNA techniques and PCR were used to construct plasmid pDK533, in which a spectinomycin resistance gene has replaced the coding region of gene orfX. Briefly, a 1.48-kb NgoMI-EcoRI DNA fragment containing the end of glyA, all of orfX, and most of lktC from strain Y4 was cloned between the XmaI and EcoRI sites of the vector pBluescript KS (Stratagene Cloning Systems, La Jolla, Calif.) to generate an intermediate plasmid called pDK527. This plasmid was linearized with AflII, which cuts just upstream of orfX, and StyI, which has a site at the termination codon of orfX; a 1.1-kb PCR product encoding spectinomycin resistance was cloned into this DNA to generate pDK533. In this plasmid, orfX has been replaced with the spectinomycin resistance gene and its promoter and transcription termination sequences. The 1.1-kb PCR product used in this protocol was generated with a primer pair that flanked the spectinomycin adenyltransferase gene of Enterococcus faecalis (19) . The primers were synthesized to contain a StyI site at the end of the sense primer (5Ј-CCCCCATGGCGTGAA TACATGTTATAATAAC-3Ј) and an AflII site on the end of the antisense primer (5Ј-CGCCTTAAGGTTTTCTAAAATCTGATTACC-3Ј). The orientation of the spectinomycin resistance gene in pDK533 is opposite to the orientation of orfX.
Plasmid pDK533 was electroporated into A. actinomycetemcomitans Y4 to produce ampicillin-resistant, spectinomycin-resistant transformants (e.g., AAM52 [see Fig. 6A ]) in which the plasmid had recombined into the host chromosome. These constructions were verified by Southern blot analysis. AAM52 and three other similar transformants were then passaged six to eight times in TSBYE without antibiotics and plated onto TSBYE for isolation. A total of 140 individual colonies were tested for their resistance to spectinomycin and ampicillin; 4 were now ampicillin sensitive but still spectinomycin resistant. These colonies should be cells in which pDK533 had recombined out of the chromosome in such a way that it left the ⌬Gene X::spec res gene in the chromosome (AAM54-57). This was confirmed by Southern blot analysis.
lktA::lacZ reporter gene plasmids: construction and isolation for three different promoters. To construct the JP2 reporter gene plasmid pDK445, a 1.65-kb PstI-SspI fragment of JP2 DNA containing 1 kb of the leukotoxin promoter region, the 500-bp lktC gene, and the DNA coding for the first 26 amino acids of LktA ( Fig. 1 ) was cloned into PstI-SmaI-digested pUC18. This allowed the same region of DNA to be isolated as a 1.65-kb PstI/KpnI DNA fragment by using the KpnI site provided by the vector. This DNA fragment was cloned into plasmid YEp358R (21) to create an in-frame fusion of the first 26 amino acids of LktA to ␤-galactosidase. The fusion junction was confirmed by DNA sequence analysis. The entire lktA::lacZ fusion gene with the JP2 promoter region was then isolated as a 4.5-kb PstI-NsiI DNA fragment and cloned into the PstI site of the broad-host-range vector pMMB67 (8, 9) to generate plasmid pDK445. A 1.05-kb SspI fragment containing 450 bp of the Y4 leukotoxin promoter region, all of lktC, and the DNA coding for the first 26 amino acids of LktA (see Fig. 1 ) was cloned into the SmaI site of pUC18 as a first step in making a Y4 lktA::lacZ reporter gene fusion plasmid. The same DNA segment was then isolated as a PstI-KpnI fragment (with KpnI at the lktA end) by using the restriction endonuclease recognition sites in the multiple-cloning site of the vector and cloned between the PstI and KpnI sites of YEp356R (21) . DNA sequence analysis was used to confirm that this plasmid had an in-frame fusion of LktA, at amino acid 26, to ␤-galactosidase. The entire lktA::lacZ fusion gene with the Y4 promoter region was then isolated as a 4.2-kb PstI-NsiI DNA fragment and cloned into the PstI site of pMMB67 (9) to generate plasmids pDK493 and pDK494; these plasmids have the insert present in opposite orientations. To put additional Y4 leukotoxin promoter region DNA onto this plasmid, a 1.0-kb NaeI-HindIII DNA fragment was isolated, HindIII linkers were added to the NaeI end, and the resulting DNA was cloned between the two HindIII sites of pDK493 to generate plasmid pDK541. The cloning junctions and insert orientation of this plasmid were confirmed by DNA sequence analysis. In plasmid pDK541, the lktA::lacZ fusion is flanked by the lktC gene and 1.2 kb of additional upstream DNA starting at the NaeI site in glyA.
The same recombinant DNA strategy used for Y4 was used to construct the ATCC 33384 reporter gene plasmid with two minor differences: the starting DNA fragment was a 1.05-kb SspI DNA fragment from the leukotoxin promoter region of strain ATCC 33384, and the final 1.0-kb HindIII fragment added to the clone was generated from a NgoMI segment to which HindIII linkers were added.
Generation of promoter deletions in the Y4 lktA::lacZ reporter gene plasmid. A series of deletions in the Y4 leukotoxin promoter region was generated by cloning various PCR products into the Y4 lktA::lacZ reporter plasmid pDK494. One primer, LKT66 (5Ј-GGGTTTTCCCAGTCACGAC-3Ј), was present in all of the PCR amplifications; it is the reverse complement of a sequence in lacZ so that the resulting PCR product will include the KpnI restriction endonuclease site at the lktA-lacZ junction. The other primers used in individual PCR amplifications (LKT68 to LKT76) annealed to sites at approximately 100-bp intervals within the Y4 leukotoxin promoter region (see Fig. 2 ). The LKT68-76 primers had a non-template encoded KpnI site at their 5Ј ends.
LKT66 was used in combination with each of the primers, LKT68 to LKT76, in PCR amplifications (30 cycles) on a PTC-100 programmable thermal controller (M. J. Research, Inc.) with plasmid pDK541 as a template. The nine resultant PCR products were made blunt ended by reaction with the Klenow fragment of DNA polymerase I, phosphorylated with T4 polynucleotide kinase and ATP, and then isolated by gel purification (2) . Each PCR fragment was cloned into the SmaI site of pUC18, isolated from those intermediate plasmids as KpnI fragments, and cloned in between the KpnI sites of plasmid pDK494. This resulted in the replacement of the full-length Y4 promoter with truncated versions of the promoter in lktA::lacZ reporter plasmids pDK563 to pDK571. Plasmid DNAs were isolated from E. coli (1, 15) , and large-scale isolations were done by a previously described modification of an alkali lysis procedure (14) . The junctions and orientations of each insert were confirmed by DNA sequence analysis.
Assay of ␤-galactosidase from lktA::lacZ reporter plasmids in A. actinomycetemcomitans. The leukotoxin promoter-lacZ fusion constructs (plasmids pDK445, pDK541, pDK543, and pDK563 to pDK571) were introduced into various strains of A. actinomycetemcomitans by electroporation (12, 27) . To measure lktA::lacZ activity, cells from a given transformant were grown overnight in 5 ml of TSBYE plus ampicillin broth in a Coy anaerobic chamber with shaking, diluted 1:25 into a flask with 25 ml of fresh medium, and grown overnight once again. The overnight culture was then diluted to an optical density at 600 nm (OD 600 ) of 0.1 in 25 ml of TSBYE. When the culture density had doubled (OD 600 Ϸ 0.2), a 1-ml aliquot was removed and assayed for ␤-galactosidase activity. Each sample was measured in triplicate as described (20) Nucleotide sequence accession numbers. The GenBank accession numbers for the Y4 and ATCC 33384 sequences are U51861 and U51862, respectively.
RESULTS
Strains producing different levels of leukotoxin have distinct sequences upstream of the leukotoxin coding region. To see if leukotoxin promoter sequence differences could readily explain the variability in lkt RNA levels seen in different strains of A. actinomycetemcomitans, the leukotoxin promoter regions from strains Y4 (leukotoxin moderate; 10% of JP2) and ATCC 33384 (leukotoxin low; 2% of JP2) were cloned, sequenced, and compared with the previously analyzed sequence of the corresponding region from strain JP2 (17) . All three sequences were identical in the lktC coding region and in the adjacent 27 bases; the upstream sequences diverged. The most dramatic variation is a 528-bp deletion in the JP2 leukotoxin promoter relative to Y4 and ATCC 33384 (Fig. 1) . The same deletion was also found by Brogan et al. (5) when comparing the leukotoxin promoter regions from strains JP2 and 652. The 528-bp deletion removes a DNA segment starting in the middle of orfX, a 450-bp open reading frame found in Y4 and ATCC 33384, and continuing to a position 54 bp 5Ј of the lktC start codon (Fig. 2) . Except for the deletion, strains Y4 and JP2 are identical in the region sequenced. This includes the end of the glyA gene which encodes serine hydroxymethyltransferase (5, 23) . On the other hand, the sequences in the glyA-to-lktC regions from Y4 and ATCC 33384 diverged from each other by 8% on average (Fig. 2) . Interestingly, the least conserved region (ϳ89% sequence identity) was in the orfX coding region.
Brogan et al. (5) previously reported that the leukotoxin operon in strain JP2 has two promoters, P 1 and P 2 , which are located 336 and 38 bp, respectively, in front of lktC. From sequence analysis, it is clear that differences in the "strengths" of the P 1 promoters from the various strains cannot be responsible for the interstrain variation in leukotoxin RNA levels; the Ϫ10 and Ϫ35 sequences of the P 1 promoter are identical in Y4, ATCC 33384 (Fig. 2) , 652 (5), and JP2. Thus, the most straightforward hypothesis would be that leukotoxin RNA synthesis in strains Y4, ATCC 33384, and 652 does not start at P 1 but instead initiates from a "weaker" promoter between the end of orfX and the beginning of lktC. Consistent with this possibility, there are a number of base pair differences among the strains in the vicinity of P 2 , any of which may lead to a weaker leukotoxin promoter in that region. In fact, the Ϫ35 sequence of P 2 in JP2 is not present in Y4 or ATCC 33384 because of the 528-bp insertion. However, this simple hypothesis appears incorrect. We will present data below indicating that there is no P 2 promoter for leukotoxin RNA synthesis in strains JP2 and Y4. This leads to the alternate hypothesis that leukotoxin RNA synthesis initiates at P 1 in all strains of A. actinomycetemcomitans but transcription through to lktC is inefficient in strains Y4, ATCC 33384, and 652 because they have an extra 528 bp DNA relative to JP2.
Leukotoxin RNA synthesis initiates at P 1 in strain JP2. To help distinguish among the possible mechanisms involved in producing lower leukotoxin RNA levels in some strains of A. actinomycetemcomitans, the lkt RNA initiation site(s) must be mapped. The leukotoxin RNA initiation site(s) was first mapped in JP2, since this strain produces the most leukotoxin RNA (25) and since we wanted to confirm the results of Brogan et al. (5) . RNA was isolated from A. actinomycetemcomitans JP2 grown to different cell densities, and S1 nuclease protection mapping was done with an end-labeled DNA fragment encompassing the region from glyA to lktC as a probe (Fig. 1) . The one RNA-dependent band was 590 bp (Fig. 3A) FIG. 1. Gene organization of the leukotoxin loci in strains of A. actinomycetemcomitans. Protein-coding regions are denoted by boxes; an open-ended box indicates that only part of a gene is shown. The position of the leukotoxin P 1 promoter is marked by an arrow, as is the position of the putative P 2 promoter in JP2 (5). The nucleic acid probe used in the S1 analysis of JP2 lkt RNA is indicated by the line above the JP2 map. The positions and orientations of the oligonucleotides used in JP2 primer extension experiments (SPITZ8) and Y4 reverse transcriptase-coupled PCR assays (LKT16, LKT56, and LKT57) are designated by small arrows. The labeled ends of the primers and probes are indicated by asterisks. The oligonucleotide sequences are as follows: SPITZ8, GGGAACTGAATAAAACGGAGATAAAATGGAGCATATTCTGTACTG GAC; LKT16, CCGGTCAAAGGTTAT; LKT56, GGTT(A/G)TAAAATAAC GG; LKT57, AATTATTATTTTTCTCCATATTAAATCTCC. Relevant restriction endonuclease sites are marked as follows: A, AflII; E, EcoRI; H, HindIII; Na, NaeI; Ng, NgoMI; P, PstI; Ss, SspI; St, StyI.
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on January 27, 2018 by guest http://iai.asm.org/ which is consistent with the major start site for lkt RNA being at P 1 . Unexpectedly, no major RNA-dependent band was found at the position expected for an RNA start site at the P 2 promoter (Fig. 1) identified by Brogan et al. (5) . Long exposures of the gels for some experiments did show a faint band at a position expected for an RNA end at the putative P 2 promoter; the low abundance of this signal seems most consistent with the possibility that the RNA end found at P 2 by Brogan et al. (5) arose from breakdown products of the leukotoxin RNA. To confirm our S1 nuclease mapping results, primer extension analyses with several primers, including the one used by Brogan et al. in their RNA end mapping experiments (5), were also performed. The major primer extension product was found at the position expected for RNA initiating at P 1 (Fig.  3B ). There was no major primer extension product above background at the position expected for an RNA initiating at P 2 ( Fig. 3C) . We conclude that the P 1 promoter is the only one used in the transcription of the leukotoxin operon of A. actinomycetemcomitans JP2. The size of the band from the S1 nuclease analysis with JP2 RNA placed the major start site for lkt RNA approximately at position Ϫ340 relative to the translational initiation codon for lktC. The base(s) at which leukotoxin RNA synthesis initiates was determined more precisely by electrophoresis of certain of the S1 nuclease and primer extension products on sequencing gels. Analysis of the primer extension products revealed two major transcript start sites corresponding to an A and a C at Ϫ336 and Ϫ337 (Fig. 3B) . A minor band at position Ϫ332 was also found in most experiments. The products of the S1 nuclease analysis yielded five bands of approximately equal intensity. Their sizes indicated that the lkt RNA initiates at positions Ϫ336, Ϫ335, Ϫ333, Ϫ331, and Ϫ330 (data not shown). The extra, slightly shorter bands found in the S1 nuclease analysis most probably result from "breathing" of the AT-rich end of the lkt RNA-DNA hybrid formed in the reaction; the 8-bp region from positions Ϫ329 through Ϫ336 is made entirely of A ⅐ T pairs. Thus, we conclude that the major transcription start sites for the leukotoxin operon in A. actinomycetemcomitans JP2 are at bases Ϫ336 and Ϫ337 from the first base of the lktC start codon. We conclude that the Ϫ10 and Ϫ35 promoter consensus sequences identified by Kraig et al. (17) at positions Ϫ344 and Ϫ366 are correct and do in fact define the leukotoxin promoter P 1 .
Leukotoxin RNA synthesis also initiates at promoter P 1 in strain Y4. To test the hypothesis, suggested by the sequence analysis, that lkt RNAs from strains Y4 and ATCC 33384 initiate at a promoter between orfX and lktC, RNA end mapping was attempted with Y4 RNA and leukotoxin-specific probes and primers. No mapping experiments were done with ATCC 33384 RNA because of the low abundance of the leukotoxin transcript. In S1 nuclease analyses with uniformly labeled antisense RNA probes, one prominent band was consistently detected; it was of the appropriate size to represent RNA which initiated at P 1 and terminated somewhere between the end of orfX and the beginning of lktC (data not shown). This was presumed to represent the orfX transcript. Two other protected DNA fragments were also usually found (data not shown). The sizes of these other two bands placed two leukotoxin RNA start sites about 160 and 375 bases before the beginning of the lktC gene (Fig. 2) . On the other hand, primer extension analysis suggested that the leukotoxin RNA initiated at four positions approximately 110, 130, 345, and 400 bases before the lktC coding region (data not shown but summarized in Fig. 2 ). The apparent discrepancy between the S1 nuclease and primer extension mapping results could be a consequence of interference from secondary structures in the leukotoxin RNA or could be an artifact due to difficulties in controlling the extent of RNA degradation or processing among samples of A. actinomycetemcomitans RNA. However, a more interesting possibility is that leukotoxin RNA synthesis initiates at P 1 in strain Y4 but that the RNA, containing the orfX and lkt genes, is rapidly cleaved at a site (or sites) between orfX and lktC. This could easily lead to a mixture of RNA ends between orfX and lktC which would be found in RNA-mapping experiments.
If this final possibility were correct, then orfX, lktC, and lktA should be cotranscribed as part of a ϳ4.6-kb RNA in strain Y4 (25) . To test for the existence of this transcript, Northern (RNA) blot analysis was done with Y4 RNA and an orfXspecific hybridization probe. Surprisingly, the only signal seen was from hybridization to a somewhat broad band of approximately 750 bases (Fig. 4A, lane a) . The lack of hybridization to a larger band did not appear to be due to general RNA degradation during sample preparation, since a ϳ4.3-kb leukotoxin RNA band was seen when the Y4 RNA was hybridized with an lktA-specific probe (Fig. 4A, lane b) . We therefore hypothesized that leukotoxin RNA synthesis initiates at the P 1 promoter to produce a primary 4.6-kb transcript containing orfX, lktC, and lktA, which is rapidly processed or degraded into two RNAs, one encoding orfX and the other encoding lktCA. The levels of this initial 4.6-kb transcript could be too low for detection by Northern blot analysis. Therefore, to provide evidence for this proposed unstable, low-abundance 4.6-kb primary RNA containing both orfX and lktC sequences, a more sensitive technique, reverse transcrip- 
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tase-coupled PCR, was used. DNase-treated RNA from A. actinomycetemcomitans Y4 was used in a reverse transcriptase reaction with the lktC-specific oligonucleotide LKT57 as a primer. This cDNA sample was then used as the PCR substrate for several orfX-specific (LKT16 and LKT56) and lktC-specific (LKT57) oligonucleotide primer pairs (Fig. 1) . Each primer pair generated a reverse transcriptase-dependent band of the size expected, 856 bp with primers LKT16/LKT57 and 699 bp with primers LKT56/LKT57 (Fig. 4B, lanes c and e) , indicating that orfX and lktC are cotranscribed. The unexpected ϳ1.4-kb PCR product in both lanes is from an irrelevant RNA, since it failed to hybridize to an oligonucleotide specific for the region between lktC and orfX (data not shown). Thus, all of the results lead us to conclude that the lktC and lktA genes are cotranscribed with orfX from P 1 in strain Y4 and that this 4.6-kb RNA is rapidly processed into two smaller RNAs, one containing orfX and a second containing lktC and lktA. To confirm that P 1 is the primary leukotoxin promoter in Y4, a series of deletions in the region upstream of the Y4 lktC gene were constructed and their effects on leukotoxin levels were assayed. These deletions were generated in a broad-host-range plasmid in which the leukotoxin structural gene (lktA) was fused, in frame, at amino acid 26 to lacZ (lktA::lacZ). Thus, the effects of the Y4 leukotoxin promoter deletions on leukotoxin synthesis could be assessed by measuring the levels of ␤-galactosidase. The plasmids with the promoter deletions were electroporated into A. actinomycetemcomitans Y4, and several transformants of each were assayed for the level of LktA-␤-galactosidase fusion protein (Fig. 5) . Deletion of the P 1 sequences (plasmids 564, 565, and 566) led to the loss of ␤-galactosidase synthesis; this suggests very strongly that leukotoxin synthesis in Y4 initiates at the P 1 promoter (as it does in strain JP2).
As expected if P 1 were the major leukotoxin promoter, the three smallest deletions led to the loss of LktA::LacZ synthesis. Surprisingly, however, the other larger deletions showed progressive increases in the level of ␤-galactosidase (Fig. 5 , plasmids pDK567 to pDK571). There are two possible explanations for these data: (i) Y4 has a second promoter near lktC that is repressed by sequences within orfX, or (ii) the isopropyl-␤-D-thiogalactopyranoside (IPTG)-inducible tac promoter (8) in the vector may drive the synthesis of LktA::LacZ in plasmids pDK567 to pDK571. We favor the latter explanation since the levels of ␤-galactosidase can be induced fourfold by IPTG in cells containing pDK569, one of the larger deletions, but only twofold in cells with pDK565, a small deletion.
To eliminate definitively the possibility that there is a promoter for leukotoxin in the region between orfX and lktC in strain Y4, an alternate molecular genetic approach was used. We generated strains of A. actinomycetemcomitans in which a spectinomycin resistance gene, with its transcription termination sequences, has replaced the normal genomic copy of orfX (Fig. 6A, AAM57 for example) . In these mutants, the P 1 promoter cannot be used to synthesize lkt RNA. If there were a second promoter immediately upstream of lktC, a leukotoxin RNA would be synthesized in these mutant strains even when the transcript from P 1 has been terminated. RNA was prepared from several orfX deletion strains (AAM54 to AAM57) and examined by Northern blot analysis with a leukotoxinspecific probe; no lkt RNA was detected (Fig. 6B, top panel) . Signals for leukotoxin RNA were found in the samples from the leukotoxin-positive strains AAM50 and AAM60 (Fig. 6B , top panel), indicating that the hybridization probe was working. As a positive control to show that the RNA samples were intact, the same blot was rehybridized with a glyA probe which gave appropriately sized signals (Fig. 6B, bottom panel) . Finally, the lack of leukotoxin RNA in the ⌬orfX strains was confirmed by checking extracts from several of the deletion mutant strains for leukotoxic activity by chromium release assays (16); no activity was found (data not shown). These results prove that a second leukotoxin promoter is not present within the 330 bases of Y4 DNA immediately upstream of lktC. This provides further evidence that the P 1 promoter must be the only one used for leukotoxin RNA synthesis in strain Y4.
However, these experiments left one, albeit remote, possibility: perhaps there is a promoter between orfX and lktC whose activation requires the presence of the protein product of orfX. To eliminate this possibility, a Northern blot analysis was performed with RNA from AAM52, an intermediate strain made in the construction of the orfX deletion mutants (Fig. 6A ). AAM52 has a complete, transcribed (data not shown) copy of orfX near but separated from the 330-bp segment upstream of lktC (Fig. 6A ), yet it synthesizes no detectable leukotoxin RNA (Fig. 6B) . Taken together, the RNAmapping results, the plasmid deletion experiments, and the orfX deletions lead us to conclude that leukotoxin RNA synthesis initiates from the same promoter, P 1 , in strains Y4 and JP2; there is no second leukotoxin promoter in strain Y4 between orfX and lktC.
Promoter differences and strain-specific trans factors are both important in determining the level of leukotoxin produced by different strains of A. actinomycetemcomitans. Having demonstrated that the JP2 and Y4 leukotoxin operons use the same promoter, P 1 , we now could begin to examine the mechanism(s) responsible for the different levels of leukotoxin expressed in the two strains and in the low-leukotoxin-expressing strain ATCC 33384. Therefore, classical cis/trans experiments were done to assess the relative contributions of promoter differences (cis elements) and possible strain-specific transcription proteins (trans factors) in determining different leukotoxin levels. To facilitate the analysis, the JP2 leukotoxin gene (lktA) and its promoter region, including P 1 and 700 bp of additional upstream DNA, were fused in frame at amino acid codon 26 to the reporter gene lacZ (26). This fusion construct was then cloned into the broad-host-range plasmid vector pMMB67 (9) to generate plasmid pDK445. Similar reporter gene plasmids were generated for the leukotoxin operons from strains Y4 and ATCC 33384. These two constructs, pDK541 and pDK543, have the same lktA::lacZ fusion but contain only 350 bp of DNA upstream of P 1 , so that the overall sizes of the three plasmids differ by less than 2%. This should ensure that there are no significant differences in plasmid copy number when they are introduced into A. actinomycetemcomitans.
The three plasmids were individually electroporated into the set of three A. actinomycetemcomitans strains, and the ␤-galactosidase levels were determined ( Table 1) . As expected, the LktA::LacZ levels were highest for the JP2 promoter plasmid in strain JP2, intermediate for the Y4 promoter plasmid in strain Y4, and low for the ATCC 33384 promoter plasmid in strain ATCC 33384 (Table 1 , top left to bottom right diagonal). The ratios of these three values, 100:22:3, are very close to the ratios 100:10:2, which we have measured directly for leukotoxin activity in JP2, Y4, and ATCC 33384 (25) . These results indicate that the reporter gene system accurately reproduces the regulation of leukotoxin in A. actinomycetemcomitans.
The data show that the JP2 promoter plasmid pDK445 gives the highest level of expression in all of the strains (Table 1) . Similarly, the ATCC 33384 promoter has the lowest levels of expression in all strains and the Y4 promoter plasmids always give intermediate levels of expression (Table 1) . Thus, we conclude that differences in the promoters play a critical role in determining the different levels of leukotoxin RNA in JP2, Y4, and ATCC 33384. In fact, the 10-fold disparity in leukotoxin levels between strains JP2 and Y4 (25) appears to be due mainly to the differences in their leukotoxin promoter regions; the ␤-galactosidase values for a given plasmid in JP2 are al- On the other hand, strain-specific trans factors must play a significant role in determining leukotoxin level differences between ATCC 33384 and the other two strains, since the levels of ␤-galactosidase from a given promoter construct are always lower in strain ATCC 33384 than in strains Y4 or JP2 (Table 1) . On the basis of these results, it is clear that differences in leukotoxin promoter sequences and in strain-specific trans factors are both important in determining the level of leukotoxin produced by different strains of A. actinomycetemcomitans.
DISCUSSION
Most strains of A. actinomycetemcomitans isolated from individuals with periodontal disease produce high levels of the virulence factor leukotoxin, whereas most strains isolated from healthy individuals produce significantly lower levels of leukotoxin (32) . We had previously shown by Northern blot analysis that the difference in the levels of leukotoxin in the assorted strains was a direct reflection of the levels of leukotoxin RNA (25) . In this study, classical cis/trans experiments were used to show that both cis regulatory elements and trans-acting transcription factors are involved in determining the different levels of leukotoxin produced among the three strains tested. Sequence comparisons and promoter mapping indicate that some of the cis elements involved in the interstrain regulation are found downstream of the leukotoxin promoter, within the transcribed region of the operon.
The leukotoxin promoter regions have been cloned and sequenced from four strains: JP2 (5, 17), a high-level leukotoxin producer; Y4 and 652 (5), which produce moderate levels of leukotoxin; and ATCC 33384, a low-level leukotoxin producer. The major difference among the sequences is that JP2 has a deletion of 528 bp that moves the first half of an open reading frame of unknown function (orfX) to a position 53 bp upstream of lktC. This is identical to the result reported by Brogan et al. (5) . This group found three additional base pair changes between the leukotoxin promoter regions of JP2 and 652, a moderate-level leukotoxin producer. These three changes are probably not important in determining the relative levels of leukotoxin produced, since we have shown that the sequence of another moderate-level producer of leukotoxin, strain Y4, is identical in sequence to JP2, except for the 528-bp deletion. Importantly, the Ϫ10 and Ϫ35 sequences that constitute the P 1 leukotoxin promoter are identical in all four strains sequenced. This indicates that the "strength" of the P 1 promoter is not the only factor in determining the different levels of lkt RNA produced by the four strains of A. actinomycetemcomitans. Finally, the sequence comparisons suggest that strains ATCC 33384 and Y4 diverged from each other before JP2 arose from Y4.
Strains Y4 and ATCC 33384 have a 450-bp open reading frame (orfX) which is truncated in JP2. Brogan et al. (5) found the same open reading frame in strain 652. This gene is transcribed (and presumably translated) in strain Y4. The predicted sequences of the OrfX proteins from the three strains are different. The six base pair changes between Y4 and 652 result in five amino acid changes, three of which are conservative. Strains ATCC 33384 and Y4 have 29 amino acid differences between their OrfX proteins, whereas the 652 and ATCC 33384 OrfX proteins differ at 31 positions. In both cases, about half of the amino acid changes are conservative and half are nonconservative. The possible effects of these amino acid changes on orfX function are unclear, since its activity is undefined; there are no close homologs in the protein databases. However, we have shown that orfX is not an essential gene under standard laboratory growth conditions, since the orfX deletion strains created for the studies reported here grow as well as do cells of the parental Y4 strain (data not shown).
Both S1 nuclease analysis and primer extension experiments clearly showed that leukotoxin RNA in strain JP2 initiates at two sites 336 and 337 bp before the lktC gene. These sites are immediately downstream of the Ϫ10 and Ϫ35 promoter consensus sequences identified by Kraig et al. (17) at positions Ϫ344 and Ϫ366 by sequence analysis. Although Brogan et al. (5) also found that the leukotoxin RNA started at Ϫ336 in JP2, they did not find the Ϫ337 start site. The reason for the discrepancy between the two sets of data is not clear, but they both lead to the conclusion that the consensus sequences at Ϫ344/Ϫ366 constitute the leukotoxin promoter called P 1 .
Unlike previous reports (5), we found no evidence for a second leukotoxin initiation site near lktC in strain JP2 even if we used the same primer as they did in a primer extension experiment. As was suggested by Brogan et al., this additional site, called P 2 , could result from an RNA degradation intermediate as opposed to being a consequence of a true initiation event. Consistent with this, we did observe a faint band at the position expected for a "P 2 " RNA on long exposures of some S1 nuclease analysis gels. In addition, Brogan et al. found 4.2-and 3.8-kb leukotoxin transcripts on Northern blots of JP2 RNA (5). The sizes and hybridization patterns of these RNAs were consistent with initiation of the 4.2-kb RNA at P 1 and initiation of the 3.8-kb RNA at P 2 , the interpretation favored by Brogan et al. (5) . Alternatively, we suggest that the 3.8-kb RNA is a relatively stable intermediate in the breakdown of the 4.2-kb lkt RNA. Our conclusion is supported by the fact that the major leukotoxin transcript we found on Northern blots of JP2 RNA was 4.3 kb (25) and by the fact that we did not see a start site at P 2 by S1 nuclease analysis or primer extension experiments. Finally, Brogan et al. (5) reported that deletion of the P 2 sequences on a leukotoxin promoter reporter gene plasmid led to a decrease in leukotoxin levels (as measured from a ␤-galactosidase fusion in E. coli). We believe that their experiments do not provide strong evidence for the existence of a P 2 promoter in JP2, for two reasons. First, there was no significant difference between the levels of LacZ expressed from the plasmid without P 2 (plasmid pLTX63) and those made from the plasmid containing an extra 70 bp of DNA, including P 2 (plasmid pLTX135) (5). Second, Brogan et al. (5) assayed their promoter constructs in E. coli, which may not reflect accurately what occurs in A. actinomycetemcomitans. Indeed, we have shown that the Y4 promoter deletion plasmids gave different absolute and relative values when the levels of LktA::LacZ were measured in E. coli and A. actinomycetemcomitans (data not shown). Therefore, we conclude that there is no second leukotoxin promoter just upstream of lktC in strain JP2.
Leukotoxin RNA synthesis in strain Y4 also appears to initiate at P 1 . This would generate an RNA transcript that should be 550 bases longer than the P 1 -initiated transcript from strain JP2. However, our previous results indicated that the major lkt transcript in strain Y4 was, if anything, slightly smaller than the major lkt RNA in JP2 (25) . This apparent discrepancy can be explained by our results with Y4, indicating that the leukotoxin RNA that initiates at P 1 is rapidly degraded or processed into an orfX-containing RNA about 750 bp in size and a 3.85-kb RNA containing lktCA. It is this latter RNA species that appears as the major leukotoxin transcript on Northern blots of Y4 RNA. From the DNA sequences, these lktCA RNAs from Y4 should be about 100 to 200 bases shorter than the major JP2 lkt transcript; this is what was observed on Northern blots (25) . The Y4 leukotoxin RNA end-mapping data are also consistent with this interpretation. Both S1 and primer extension analyses indicate that there is a leukotoxin RNA end in the region between orfX and lktC, but the results are often different between experiments. This could arise from the distinct possibility that the leukotoxin RNA is degraded or processed to somewhat different extents in different experiments. It is not clear whether this processing occurs in vivo or during sample preparation.
Why are leukotoxin levels lower in strain Y4 than in JP2? The cis/trans experiments indicate that the different leukotoxin levels are due mainly, if not solely, to differences in the sequences in the leukotoxin regions of these two strains. Since both JP2 and Y4 lkt RNA initiate at the P 1 promoter and since the only sequence difference between the two leukotoxin regions is the extra 528 bp between orfX and lktC in Y4, there must be a sequence in the 528-bp element that is involved in down-regulating Y4 leukotoxin RNA relative to JP2 lkt RNA. Several mechanisms are possible for this down-regulation, including specific RNA turnover and termination models; these are being investigated.
Why are leukotoxin levels lower in ATCC 33384 than in JP2 (and Y4)? In this case, the cis/trans experiments indicate that the 30-fold difference in lkt RNA levels between strain JP2 and strain ATCC 33384 is due equally to cis (promoter sequence) and trans (strain-specific DNA binding factor) effects. Specifically, the extent of the trans effect is demonstrated by the fact that the level of LktA::LacZ from an ATCC 33384 promoter construct (pDK543) is six-to sevenfold lower in strain ATCC 33384 than in strain JP2 (Table 1) . One possibility is that the levels are lower in strain ATCC 33384 because the plasmid copy number is lower in that specific strain. We do not think that this is true, for two reasons. First, the vector used encodes its own replication initiation proteins. Second, if the lower LktA:LacZ levels in ATCC 33384 were due to a lower plasmid copy number, the ratio of ␤-galactosidase between ATCC 33384 and Y4 (or ATCC 33384 and JP2) for a given plasmid should be the same for all three plasmids. This was not the case (Table 1) . However, even if the plasmids had lower copy numbers in ATCC 33384, the data would still lead to the conclusion that there are trans factor differences among the strains, although their contribution to the different leukotoxin levels would not be as great. Thus, we conclude that there must be a regulatory protein that controls a portion of the interstrain difference in expression. We hypothesize that either strain ATCC 33384 has a negative regulatory protein (that is missing or mutated in Y4 and JP2) or that JP2 and Y4 carry an activator that is missing or mutated in ATCC 33384. This factor (positive or negative) is presumed to work in regulating the initiation of transcription from the leukotoxin P 1 promoter. Studies are under way to identify and characterize the protein involved in the interstrain regulation of leukotoxin RNA synthesis.
